Literature DB >> 22610563

Isolation, culture, and osteogenic/chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.

Susanne Grässel1, Sabine Stöckl, Zsuzsa Jenei-Lanzl.   

Abstract

Musculoskeletal disorders, as non-healing fractures and large bone defects, articular cartilage and subchondral bone injuries, often result in lifelong chronic pain and compromised quality of life. Although generally a natural process, failure of large bone defects to heal such as after complex fractures, resection of tumours, infections, or revisions of joint replacements remains a critical challenge that requires more appropriate solutions as those currently available. In addition, regeneration of chondral and osteochondral defects continues to be a challenge until to date. A profound understanding of the underlying mechanisms of endogenous regeneration is a prerequisite for successful bone and cartilage regeneration. Presently, one of the most promising therapeutic approaches is cell-based tissue engineering which provides a healthy population of cells to the injured site. Use of differentiated cells has severe limitations; an excellent alternative would be the application of adult marrow stromal cells/mesenchymal stem cells (MSC) which possess extensive proliferation potential and proven capability to differentiate along the osteochondral pathway. The process of osteo-/chondrogenesis can be mimicked in vitro by inducing osteo-chondroprogenitor stem cells to undergo osteogenesis and chondrogenesis through exposure of osteo-/chondrogenic favourable microenvironmental, mechanical, and nutritional conditions. This chapter provides comprehensive protocols for the isolation, expansion, and osteo-/chondrogenic differentiation of adult bone marrow-derived MSC.

Entities:  

Mesh:

Year:  2012        PMID: 22610563     DOI: 10.1007/978-1-61779-815-3_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

Review 1.  Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration.

Authors:  Xiangxin Lou
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

2.  Osseointegrative properties of electrospun hydroxyapatite-containing nanofibrous chitosan scaffolds.

Authors:  Michael E Frohbergh; Anya Katsman; Mark J Mondrinos; Collin T Stabler; Kurt D Hankenson; Jeffrey T Oristaglio; Peter I Lelkes
Journal:  Tissue Eng Part A       Date:  2014-12-16       Impact factor: 3.845

3.  Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.

Authors:  Siying Zhong; Xufeng He; Yuexia Li; Xiangxin Lou
Journal:  Tissue Eng Regen Med       Date:  2019-01-29       Impact factor: 4.169

4.  Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis.

Authors:  Peizhou Jiang; Peng Huang; Shu-Hui Yen; Abba C Zubair; Dennis W Dickson
Journal:  Cytotherapy       Date:  2016-10-06       Impact factor: 5.414

5.  The Rho kinase inhibitor Y-27632 facilitates the differentiation of bone marrow mesenchymal stem cells.

Authors:  Xiao Liu; Zhengzheng Zhang; Xianliang Yan; He Liu; Licai Zhang; Aiming Yao; Chengcheng Guo; Xiaoyun Liu; Tie Xu
Journal:  J Mol Histol       Date:  2014-09-02       Impact factor: 2.611

6.  Differentiation of bone marrow mesenchymal stem cells into chondrocytes after short term culture in alkaline medium.

Authors:  Farshad Homayouni Moghadam; Tahereh Tayebi; Maryam Dehghan; Gilda Eslami; Hamid Nadri; Alireza Moradi; Hassanali Vahedian-Ardakani; Kazem Barzegar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014-10-01

7.  Activation of Notch1 signalling promotes multi-lineage differentiation of c-Kit(POS)/NKX2.5(POS) bone marrow stem cells: implication in stem cell translational medicine.

Authors:  Ranran Ding; Xiaofan Jiang; Yanping Ha; Zhenliang Wang; Junli Guo; Hanguo Jiang; Shaojiang Zheng; Zhihua Shen; Wei Jie
Journal:  Stem Cell Res Ther       Date:  2015-05-09       Impact factor: 6.832

8.  Epigenetic regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in culture.

Authors:  Mohamadreza Baghaban Eslaminejad; Nesa Fani; Maryam Shahhoseini
Journal:  Cell J       Date:  2013-05-05       Impact factor: 2.479

9.  The effect of bone allografts combined with bone marrow stromal cells on the healing of segmental bone defects in a sheep model.

Authors:  Marco Bernardo C Fernandes; João Antônio Matheus Guimarães; Priscila Ladeira Casado; Amanda dos Santos Cavalcanti; Natalia N Gonçalves; Carlos E Ambrósio; Fernando Rodrigues; Ana Carolina F Pinto; Maria Angélica Miglino; Maria Eugênia L Duarte
Journal:  BMC Vet Res       Date:  2014-02-05       Impact factor: 2.741

10.  Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.

Authors:  Priscila Keiko Matsumoto Martin; Roberta Sessa Stilhano; Vivian Yochiko Samoto; Christina Maeda Takiya; Giovani Bravin Peres; Yara Maria Correa da Silva Michelacci; Flavia Helena da Silva; Vanessa Gonçalves Pereira; Vânia D'Almeida; Fabio Luiz Navarro Marques; Andreia Hanada Otake; Roger Chammas; Sang Won Han
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.